Treatment of Irritable Bowel Syndrome: Sex and Gender Specific Aspects-Reference-Cited by-同舟云学术

Treatment of Irritable Bowel Syndrome: Sex and Gender Specific Aspects

Published:2012-09-05 Issue: Volume: Page:473-497
ISSN:0171-2004
Container-title:Sex and Gender Differences in Pharmacology
language:
Short-container-title:

Author:

Voß Ulrike,Lewerenz Anne,Nieber Karen

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-30726-3_21.pdf

Reference116 articles.

1. Adeyemo MA, Chang L (2008) New treatments for irritable bowel syndrome in women. Womens Health 4:605–623. doi: 10.2217/17455057.4.6.605

2. Adeyemo MA, Spiegel BMR, Chang L (2010) Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther 32:738–755. doi: 10.1111/j.1365-2036.2010.04409.x

3. Ahlawat SK, Cuddihy MT, Locke GR 3rd (2006) Gender-related differences in dyspepsia: a qualitative systematic review. Gend Med 3:31–42. doi: 10.1016/S1550-8579(06)80192-0

4. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002) Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97(suppl):S1–S5

5. Ashburn TT, Gupta MS (2006) The IBS market. Nat Rev Drug Discov 55:99–100. doi: 10.1038/nrd1961

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility and optimal cut-off point of the Somatic Symptom Scale-8 for central sensitization syndrome among outpatients with somatic symptoms and related disorders;BioPsychoSocial Medicine;2022-11-22

2. Utility and Optimal Cut-off point of the Somatic Symptom Scale-8 in severe Somatic Symptoms and Related Disorders with Central Sensitization Syndrome;2022-08-25

3. Translation, cross-cultural adaptation, and measurement properties of the Nepali version of the central sensitization inventory (CSI);BMC Neurology;2020-07-27

4. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome;Expert Opinion on Drug Metabolism & Toxicology;2020-06-18

5. Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program;The Spine Journal;2017-12